Molecular mechanisms underlying increased radiosensitivity in human papillomavirus-associated oropharyngeal squamous cell carcinoma
- PMID: 32140071
- PMCID: PMC7053336
- DOI: 10.7150/ijbs.40880
Molecular mechanisms underlying increased radiosensitivity in human papillomavirus-associated oropharyngeal squamous cell carcinoma
Abstract
Oropharyngeal squamous cell carcinoma (OPSCC) is an important type of head and neck squamous cell carcinoma (HNSCC). The traditional risk factors for OPSCC include carcinogen intake, smoking, alcohol consumption, and lifestyle. In recent years, cases of human papillomavirus (HPV)-related OPSCC have gradually increased. At present, HPV-related OPSCC in developed Western countries comprise up to 90% of all OPSCC cases, while in other developing countries, the proportion of HPV-related OPSCC cases is also gradually increasing. Compared with HPV-negative OPSCC, HPV-positive OPSCC patients have better overall survival rates and local control rates and this improved prognosis may be related to the increased radiosensitivity of HPV-positive tumors. Due to this more favorable prognosis, many downgraded treatment schemes are gradually emerging, including simple radiotherapy instead of concurrent radiotherapy or reduced radiotherapy dose. However, there is insufficient theoretical basis for such schemes. Some studies have shown that delayed repair of DNA damage after radiation, G2/M arrest, increased hypoxia, and decreased proliferation capacity are the main reasons for the increased radiosensitivity of HPV-positive tumor cells. In this review, we discuss the four principles of tumor cell damage caused by radiation, including repair, reoxygenation, redistribution, and regeneration in order to reveal the mechanism whereby HPV increases the radiosensitivity of tumor cells. An attempt was made to provide sufficient information to facilitate more individualized treatment for HPV-positive OPSCC patients, under the premise of good tumor control.
Keywords: human papillomavirus; oropharyngeal squamous cell carcinoma; radiosensitivity; redistribution; regeneration; reoxygenation; repair.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures
Similar articles
-
Sensitivity of human papillomavirus‑positive and ‑negative oropharyngeal cancer cell lines to ionizing irradiation.Oncol Rep. 2020 Oct;44(4):1717-1726. doi: 10.3892/or.2020.7709. Epub 2020 Jul 31. Oncol Rep. 2020. PMID: 32945506
-
Misregulation of DNA damage repair pathways in HPV-positive head and neck squamous cell carcinoma contributes to cellular radiosensitivity.Oncotarget. 2017 May 2;8(18):29963-29975. doi: 10.18632/oncotarget.16265. Oncotarget. 2017. PMID: 28415784 Free PMC article.
-
Predicting the radiosensitivity of HPV-negative oropharyngeal squamous cell carcinoma using miR-130b.Acta Otolaryngol. 2021 Jun;141(6):640-645. doi: 10.1080/00016489.2021.1897160. Epub 2021 Apr 1. Acta Otolaryngol. 2021. PMID: 33794725
-
The molecular mechanisms of increased radiosensitivity of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC): an extensive review.J Otolaryngol Head Neck Surg. 2018 Sep 21;47(1):59. doi: 10.1186/s40463-018-0302-y. J Otolaryngol Head Neck Surg. 2018. PMID: 30241572 Free PMC article. Review.
-
Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives.Cancer Treat Rev. 2015 Dec;41(10):844-52. doi: 10.1016/j.ctrv.2015.10.001. Epub 2015 Oct 13. Cancer Treat Rev. 2015. PMID: 26476574 Review.
Cited by
-
Genetic Mutations Associated with Inflammatory Response Caused by HPV Integration in Oropharyngeal Squamous Cell Carcinoma.Biomedicines. 2023 Dec 21;12(1):24. doi: 10.3390/biomedicines12010024. Biomedicines. 2023. PMID: 38275384 Free PMC article.
-
[Research progress in diagnosis and treatment of HPV-associated oropharyngeal squamous cell carcinoma].Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 Sep;37(9):734-739. doi: 10.13201/j.issn.2096-7993.2023.09.009. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023. PMID: 37640996 Free PMC article. Review. Chinese.
-
Deficient Radiation Transcription Response in COVID-19 Patients.Adv Radiat Oncol. 2023 Mar 25;8(4):101215. doi: 10.1016/j.adro.2023.101215. eCollection 2023 Jul-Aug. Adv Radiat Oncol. 2023. PMID: 37152486 Free PMC article.
-
Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma.Cancer Drug Resist. 2023 Feb 21;6(1):116-137. doi: 10.20517/cdr.2022.107. eCollection 2023. Cancer Drug Resist. 2023. PMID: 37065869 Free PMC article. Review.
-
Cooperation effects of radiation and ferroptosis on tumor suppression and radiation injury.Front Cell Dev Biol. 2022 Sep 13;10:951116. doi: 10.3389/fcell.2022.951116. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36176274 Free PMC article. Review.
References
-
- Duray A, Descamps G, Decaestecker C, Remmelink M, Sirtaine N, Lechien J. et al. Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma. The Laryngoscope. 2012;122:1558–65. - PubMed
-
- Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. European journal of cancer (Oxford, England: 1990) 2010;46:765–81. - PubMed
-
- Browman GP, Mohide EA, Willan A, Hodson I, Wong G, Grimard L. et al. Association between smoking during radiotherapy and prognosis in head and neck cancer: a follow-up study. Head & neck. 2002;24:1031–7. - PubMed
-
- Syrjanen K, Syrjanen S, Pyrhonen S. Human papilloma virus (HPV) antigens in lesions of laryngeal squamous cell carcinomas. ORL; journal for oto-rhino-laryngology and its related specialties. 1982;44:323–34. - PubMed
-
- Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L. et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. Journal of the National Cancer Institute. 2000;92:709–20. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
